1. Market Research
  2. > Pharmesis International Ltd. (BFK) - Financial and Strategic SWOT Analysis Review

Pharmesis International Ltd. (BFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Pharmesis International Ltd. (Pharmesis) is a pharmaceutical company that carries out the research, development production, and commercialization of Western medicines and traditional Chinese medicines. The company provides formulated products such as anetholtrithione (ATT) for the treatment of illnesses related to the liver and gall bladder. It provides products such as kinna, longlife and health supplements. The company has production facilities in the cities of Chengdu and Guilin in the Sichuan Province. For research and development, it collaborates with research institutes in China to identify and develop new drugs. Pharmesis sells its products all over China through an established sales and marketing network. The company operates through two subsidiaries, Chengdu Kinna Pharmaceutical Co., Ltd and Sichuan Longlife Pharmaceutical Co., Ltd. Pharmesis is headquartered in Chengdu, Sichuan, China.

Pharmesis International Ltd. Key Recent Developments

Feb 27, 2015: Pharmesis Announces Full Yearly Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Pharmesis International Ltd. (BFK) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Pharmesis International Ltd. - Key Facts 6
Pharmesis International Ltd. - Key Employees 7
Pharmesis International Ltd. - Key Employee Biographies 8
Pharmesis International Ltd. - Major Products and Services 9
Pharmesis International Ltd. - History 10
Pharmesis International Ltd. - Company Statement 11
Pharmesis International Ltd. - Locations And Subsidiaries 13
Head Office 13
Other Locations and Subsidiaries 13
Section 2 - Company Analysis 14
Pharmesis International Ltd. - Business Description 14
Pharmesis International Ltd. - Corporate Strategy 15
Pharmesis International Ltd. - SWOT Analysis 16
SWOT Analysis - Overview 16
Pharmesis International Ltd. - Strengths 16
Strength - Extensive Product Offerings 16
Strength - Focused RandD Activities 16
Strength - Production Facilities 16
Pharmesis International Ltd. - Weaknesses 17
Weakness - Decline in Western drugs segment 17
Pharmesis International Ltd. - Opportunities 18
Opportunity - Chinese Pharmaceutical Market 18
Opportunity - Market Potential: HCV 18
Opportunity - Growing Aged Population in China 18
Pharmesis International Ltd. - Threats 19
Threat - Stringent Government Regulations 19
Threat - Intense Competition 19
Threat - Uncertain RandD Outcomes 19
Pharmesis International Ltd. - Key Competitors 20
Section 3 - Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 - Company's Recent Developments 26
Feb 27, 2015: Pharmesis Announces Full Yearly Results 26
Section 5 - Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Pharmesis International Ltd., Key Facts 6
Pharmesis International Ltd., Key Employees 7
Pharmesis International Ltd., Key Employee Biographies 8
Pharmesis International Ltd., Major Products and Services 9
Pharmesis International Ltd., History 10
Pharmesis International Ltd., Other Locations 13
Pharmesis International Ltd., Subsidiaries 13
Pharmesis International Ltd., Key Competitors 20
Pharmesis International Ltd., Ratios based on current share price 21
Pharmesis International Ltd., Annual Ratios 22
Pharmesis International Ltd., Interim Ratios 24
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Pharmesis International Ltd., Performance Chart (2011 - 2015) 23
Pharmesis International Ltd., Ratio Charts 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.